| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.28 | 5e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.27 | 5e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |